By Anne Harding NEW YORK (Reuters Health) – A thermoplastic heat-molded mandibular-advancement device (MAD) is non-inferior to a custom-made MAD for treating obstructive sleep apnea (OSA), a new two-month randomized trial shows. “This is really a noninferiority message, for shorter treatment in moderate-to-severe sleep-apnea patients,” Dr. Jean Louis Pepin of Universite Grenoble Alpes in Saint-Martin-d’Heres,...